Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydie Trautmann

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Trends in Immunology|June 6, 2017
T Cell Immunity and Zika Virus Vaccine DevelopmentNoemia S Lima, Morgane Rolland, Kayvon Modjarrad, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapiesNicolas Chomont, Lydie Trautmann, Jean-Pierre Routy, et al.
Journal of Virology|April 10, 2015
SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 ReplicationSean Paz, Michael L Lu, Hiroshi Takata, et al.
Journal of Immunological Methods|October 15, 2011
Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cellsFlorentin-Martial Mbitikon-Kobo, Marc Bonneville, Rafick-Pierre Sekaly, et al.
The Lancet. HIV|June 3, 2026
Consideration of brain health in ART interruption studies - Authors' replyDonn J Colby, Krista L Dong, Mark F Cotton, et al.
STAR Protocols|August 8, 2024
Protocol for measuring killing capacity and intracellular cytokine production of human HIV antigen-specific CD8 T cells using flow cytometryCéline Gubser, Rachel D Pascoe, Lydie Trautmann, et al.
Mbio|July 9, 2015
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from LatencyGuillaume Mousseau, Cari F Kessing, Rémi Fromentin, et al.
The Journal of Experimental Medicine|February 6, 2002
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10Xavier Saulquin, Emmanuel Scotet, Lydie Trautmann, et al.
European Journal of Immunology|January 31, 2003
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigensLydie Trautmann, Nathalie Labarrière, Francine Jotereau, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Trends in Immunology|June 6, 2017
T Cell Immunity and Zika Virus Vaccine DevelopmentNoemia S Lima, Morgane Rolland, Kayvon Modjarrad, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapiesNicolas Chomont, Lydie Trautmann, Jean-Pierre Routy, et al.
Journal of Virology|April 10, 2015
SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 ReplicationSean Paz, Michael L Lu, Hiroshi Takata, et al.
Journal of Immunological Methods|October 15, 2011
Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cellsFlorentin-Martial Mbitikon-Kobo, Marc Bonneville, Rafick-Pierre Sekaly, et al.
The Lancet. HIV|June 3, 2026
Consideration of brain health in ART interruption studies - Authors' replyDonn J Colby, Krista L Dong, Mark F Cotton, et al.
STAR Protocols|August 8, 2024
Protocol for measuring killing capacity and intracellular cytokine production of human HIV antigen-specific CD8 T cells using flow cytometryCéline Gubser, Rachel D Pascoe, Lydie Trautmann, et al.
Mbio|July 9, 2015
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from LatencyGuillaume Mousseau, Cari F Kessing, Rémi Fromentin, et al.
The Journal of Experimental Medicine|February 6, 2002
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10Xavier Saulquin, Emmanuel Scotet, Lydie Trautmann, et al.
European Journal of Immunology|January 31, 2003
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigensLydie Trautmann, Nathalie Labarrière, Francine Jotereau, et al.
Pageof 9